Gehrig T

Title : A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation - Reichau_2026_ACS.Chem.Neurosci__

Author(s) : Reichau K , Crouzier L , Poeta E , Gehrig T , Schaller E , Zvejniece L , Meunier J , Sotriffer C , Monti B , Maurice T , Decker M

Ref : ACS Chem Neurosci , : , 2026

Abstract :

PubMedSearch : Reichau_2026_ACS.Chem.Neurosci__

PubMedID: 41593428

Title : Targeting Neuroinflammation by Activation of the Sigma-1 Receptor (S1R) and Inhibition of Butyrylcholinesterase (hBChE) Leads to Highly Potent Anti-Amnesic Compounds in an Alzheimers Disease Mouse Model - Reichau_2026_J.Med.Chem_305_118486

Author(s) : Reichau K , Crouzier L , Gehrig T , Flake A , Schaller E , Meunier J , Bertrand-Gaday C , Chatonnet A , Zvejniece L , Sotriffer C , Maurice T , Decker M

Ref : Journal of Medicinal Chemistry , 305 :118486 , 2025

Abstract :

PubMedSearch : Reichau_2026_J.Med.Chem_305_118486

PubMedID: 41547241

Gehrig T

References (2)

1. A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation - Reichau_2026_ACS.Chem.Neurosci__

2. Targeting Neuroinflammation by Activation of the Sigma-1 Receptor (S1R) and Inhibition of Butyrylcholinesterase (hBChE) Leads to Highly Potent Anti-Amnesic Compounds in an Alzheimers Disease Mouse Model - Reichau_2026_J.Med.Chem_305_118486